Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Monogram Orthopaedics Inc ( (MGRM) ) just unveiled an announcement.
On July 9, 2025, Monogram Orthopaedics Inc. terminated its Exclusive License Agreement with the Icahn School of Medicine at Mount Sinai, effective July 10, 2025. As part of the termination, Monogram agreed to a $4,000,000 payment, comprising $500,000 in cash and 35,000 shares of Series E Preferred Stock, to Mount Sinai. This termination reverts all licensed intellectual property rights back to Mount Sinai. Furthermore, Monogram’s Board of Directors adopted a Certificate of Designation for Series E Redeemable Perpetual Preferred Stock on July 11, 2025, establishing the terms and conditions for these shares, which rank senior to common stock and offer specific liquidation preferences and conversion rights.
The most recent analyst rating on (MGRM) stock is a Buy with a $4.00 price target. To see the full list of analyst forecasts on Monogram Orthopaedics Inc stock, see the MGRM Stock Forecast page.
Spark’s Take on MGRM Stock
According to Spark, TipRanks’ AI Analyst, MGRM is a Neutral.
Monogram Orthopaedics Inc. shows promise due to significant technological advancements and recent regulatory clearances, which are key drivers for potential growth. However, financial instability, regulatory uncertainties, and ongoing profitability challenges weigh heavily on the overall score. The stock’s upward momentum is a positive indicator, but valuation metrics remain weak due to negative earnings and lack of dividends.
To see Spark’s full report on MGRM stock, click here.
More about Monogram Orthopaedics Inc
Monogram Orthopaedics Inc. operates in the medical technology industry, focusing on developing innovative orthopedic solutions. The company is known for its advanced surgical robotics and personalized joint replacement implants, aiming to enhance precision and outcomes in orthopedic surgeries.
Average Trading Volume: 59,828
Technical Sentiment Signal: Strong Buy
Find detailed analytics on MGRM stock on TipRanks’ Stock Analysis page.